PV-0476: Equivalent cancer-specific survival following surgical resection or SABR for stage I lung cancer

Spencer, K orcid.org/0000-0002-6846-4341, Kennedy, M, Lummis, K et al. (5 more authors) (2018) PV-0476: Equivalent cancer-specific survival following surgical resection or SABR for stage I lung cancer. In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S244-S245.

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Elsevier Ireland Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/4.0/.
Dates:
  • Accepted: 15 December 2017
  • Published (online): 18 June 2018
  • Published: April 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP)
Depositing User: Symplectic Publications
Date Deposited: 14 Aug 2018 11:28
Last Modified: 25 Jun 2023 21:28
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/S0167-8140(18)30786-2

Export

Statistics


CORE (COnnecting REpositories)